Article | January 11, 2021

How Single-Use Technology Will Be Critical To The Commercialization Of Cell And Gene Therapies

Source: Avantor

By Timothy Korwan, Director, New Product Introduction, Avantor, Inc.

cell therapy (002)

Scaling up cell & gene therapies from research and development to commercialization is creating a new set of challenges for manufacturers. With the urgent demand of speeding up the market reach for these life-altering innovative therapies a high risk is inherent to implement inefficient workflow processes. This article will demonstrate how adopting innovative single-use solutions for in-process sampling can have a tremendous effect in efficiency and effectiveness to the workflow. Single-use solutions continue to provide productive strategies in effectively scaling up these processes while reducing risks and costs. 

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: